JAK2V617F mutation prevalence on Chilean adults suffering from primary mesenteric and portal venous thromboses.

Mauricio Burotto Lucía Del Valle-BatallaRaúl Castillo-AstorgaArnaldo Marín ValdésGuillermo Conte Lanza

Published in: International journal of laboratory hematology (2020)

In this Chilean cohort, half of mesenteric or portal venous thrombosis showed no secondary cause. In this group, the main causes were MPN and hereditary thrombophilia. Nearly, all MPN patients had JAK2V617F mutation, but there was a group of patients having JAK2V617F mutation but did not meet MPN criteria.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
risk factors
patient reported outcomes